Deanna Dubay
Psychiatric/Mental Health · Oscoda, MINPI 1346898228
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,414 of the $5,955 with a category attached, or 74.1%. 20 manufacturers reported payments, led by Johnson & Johnson at 26.6% of the total. Reporting peaked in 2023 at $3,282 and has fallen 91.3% since, to $284 in 2025. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$563
- Lundbeck LLC$492
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$418
- AbbVie$363
- plus $2K from 14 others
What the payments were for
- Travel & lodging$1,06018%
- Food & beverage$4,41474%
- Education$4818%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $1,585 |
| Teva Pharmaceuticals USA, Inc. | 59 | $1,010 |
| Alkermes, Inc. | 29 | $563 |
| Lundbeck LLC | 46 | $492 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $418 |
| AbbVie | 28 | $363 |
| Neurocrine Biosciences, Inc. | 21 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $264 |
| Otsuka America Pharmaceutical, Inc. | 12 | $233 |
| Indivior Inc. | 12 | $230 |
| Axsome Therapeutics, Inc. | 9 | $163 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Corium, LLC | 2 | $47 |
| OWP Pharmaceuticals, Inc. | 2 | $40 |
| Novo Nordisk | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| Bioxcel Therapeutics, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$1,139
How this compares
$5,955 in reported general payments places this provider in the 90th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 45 | $3,748 |
| Aripiprazole | 47 | $3,105 |
| Trazodone Hcl | 91 | $2,135 |
| Clozapine | 47 | $2,089 |
| Lurasidone Hcl | 13 | $1,668 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 53 | $1,410 |
| Bupropion XlBupropion Hcl | 22 | $1,103 |
| Lamotrigine | 65 | $973 |
| Escitalopram Oxalate | 66 | $864 |
| Fluoxetine Hcl | 35 | $812 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $749 |
| Buspirone Hcl | 49 | $708 |
| Doxepin Hcl | 20 | $704 |
| Quetiapine Fumarate | 35 | $695 |
| Hydroxyzine Hcl | 44 | $685 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Oscoda
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.